FREE WEBINAR: Psychedelics For Psychiatrists – At The Forefront Of A Paradigm Shift For Mental-illness · Mind Medicine Australia
Mind Medicine Australia logo
Donate

FREE WEBINAR: Psychedelics For Psychiatrists – At The Forefront Of A Paradigm Shift For Mental-illness

With Dr Eli Kotler, Dr Tra-ill Dowie, Tania de Jong AM and Peter Hunt AM

Date: Tue 11 May 2021 @ 7:00pm
Location: Webinar (online)

Don’t miss out – Get your tickets early!

Join this FREE, 75-minute online webinar to gain access to insights and learn about ground-breaking treatments to chronic mental health conditions.

Dr Eli Kotler and Mind Medicine Australia will share a special presentation on Psychedelic-Assisted Therapies for psychiatrists from a trauma-informed perspective. Dr Kotler is is a consultant psychiatrist, holds an academic position at Monash University through the Alfred Psychiatry Research Centre, and is the medical director of Malvern Private Hospital, the first addiction hospital in Australia. He is a member of the Australasian Professional Society on Alcohol and other Drugs (APSAD).

Dr Kotler is also one of the 50 students in the first intake of Mind Medicine Australia’s Certificate in Psychedelic-Assisted Therapies (CPAT) with psychiatrists, psychologists, psychotherapists, GPs, addiction specialists, social workers, occupational therapists and counsellors.

Following the presentation there will be a Q & A Panel with Dr Eli Kotler, Dr Tra-ill Dowie, Tania de Jong AM and Peter Hunt AM. They will answer your questions and discuss next steps with SAS-B pathways for your patients to receive psilocybin and MDMA assisted treatments, the CPAT Course and other support offered, and next steps forward for Australia in this exciting field.

WEBINAR SESSION

Date: Tuesday 11 May 2021
Time: 6:55pm for 7:00pm start – 8:15pm (incl Q&A) (AEST)

The presentation WILL BEGIN AT 7:00pm.

Location: Online. A link will be emailed to you with the viewing details.

Support these events:

Whilst our webinars are free of charge, we strongly encourage you to make a donation and support our important mission of making these therapies available through our medical system. This can be done at the time of reserving your ticket. Please share these events with your networks.

This will be an opportunity to engage in a discussion about psychedelic-assisted psychotherapies for mental illness broadly, and what Mind Medicine Australia and other local organisations are doing here in Australia.

About medicinal psychedelic treatments

Psychedelic-assisted treatments offer enormous potential in providing a meaningful alternative to current treatments for mental illness. PTSD is a debilitating condition that affects tens of millions of people worldwide, with many more trauma victims diagnosed with comorbid conditions such as depression, anxiety and eating disorders. In recent clinical trials, MDMA has been shown to produce reliable clinical improvements, restoring patient safety and self-agency even for individuals who have suffered with PTSD for many years, and for whom many treatments have failed.

The wave of clinical psychedelic research and regulatory support is rapidly building, with experts forecasting the availability of psychedelic-assisted treatments in the US and EU within the next 2 to 5 years, subject to positive clinical outcomes in large trials that are currently underway.

The Presenters

Dr Eli Kotler

MBBS MPM FRANZCP Cert. Old Age Psych. AFRACMA

Psychiatrist and Medical Director at Malvern Private Hospital

Eli is a consultant psychiatrist and psychodynamic psychotherapist. He is the Medical Director of Malvern Private Hospital, an addiction and trauma hospital in Melbourne. Eli completed the inaugural CPAT course, and has since been on its faculty. He was appointed as the course’s Australian Course Director in 2023.

As a psychiatric trainee, Eli was awarded the Royal College of Psychiatrists Trainee Prize for his Scholarly Project on Depression, as well as a Research Committee Trainee award for his work on Philosophy of Mind. As an adjunct lecturer at Monash University, he oversees medical students on their addiction medicine rotation, and sneaks in lectures on Philosophy of Mind, Psychodynamic Psychiatry and Psychedelic Assisted Therapies (PAT). He has been invited as a key-note speaker by the RANZCP and International Psychoanalytic Association to lecture on PAT. He has been invited by the Victorian Government to design new addiction programs and works with the AFL players association.

Eli is an Associate Fellow of the Royal Australasian College of Medical Administrators, and is a member of the Australasian Professional Society on Alcohol and other Drugs. He also has extensive research experience with novel therapeutics for neurodegenerative diseases. He sits on the Victorian Medical Panels, and is an expert witness in historical abuse cases.

Clinically, Eli works in a psychodynamic framework, and attempts to help his patients find freedom from their addictions and trauma through relational experiences, and experiential self-awareness. He is actively treating patients in Australia with MDMA-assisted therapy.

Dr Tra-ill Dowie

PhD

Psychotherapist, Head of the Faculty of Psychotherapy at Ikon Institute Australia and Director of the Mind Medicine Institute

Dr Traill Dowie is a polymath philosopher, academic, psychotherapist, minister of religion and martial artist. He holds dual PhDs in Philosophy and Psychiatry. Traill is a co-founder of the Mind Medicine Institute, the head of school at Ikon Institute, a research fellow at La Trobe University in Philosophy, sub-editor of the Philosophy International Journal (Medwin Press) and has also trained with the Multidisciplinary Association of Psychedelic Studies (MAPS) and completed their clinician qualification.

Traill is a lifelong martial artist, holding black belts in multiple disciplines. He has worked professionally as both an athletic and performance coach for high level athletes, including world champions, at a national and international level.

Growing up in the Northern Territory, Traill spent a lot of time on country where he developed an interest in ethnomedicine and traditional healing practices. This interest led Traill to Dr Raphael Locke, an anthropologist, psychoanalyst, consciousness researcher and initiated Iroquois shaman. Traill apprenticed with Dr Locke in shamanic practice for 20 years and has explored ethno-medicine and traditional practices across Australia, Asia, Central America and North America. This interest in healing and state-based technologies has been coupled with his interest in psychotherapy and psychology.

Traill has 25 years of experience working as a clinician in a variety of settings including in private practice and organisations. He began his career working in eco-psychotherapy and wilderness therapy working with complex presentations. Traill has worked in both in-patient and outpatient settings focusing on the treatment of complex trauma. Traill was the co-founder of Integrative Psychology where he co-authored a paper with his colleagues Nigel Denning and Linda Tilgner, which was tabled at the Royal Commission into Institutional Responses to Child Sexual Abuse. He worked with Nigel Denning to develop a protocol for individual and group psychotherapy for victims of cult abuse. Traill also chaired the Australian Counselling Association’s Trauma Standards Panel.

Tania de Jong AM

LL.B (Hons), GradDipMus

Co-founder Mind Medicine Australia, Founder Creative Universe, Creativity Australia, The Song Room & Creative Innovation Global

Tania de Jong AM is the co-Founder and Executive Director of Mind Medicine Australia. She regularly presents on psychedelic-assisted therapies, mental health and wellbeing at major conferences and events around the world and to Governments, regulators, clinicians, philanthropists and the general public.

Tania is one of Australia’s most successful female entrepreneurs and innovators developing 6 businesses and 4 charities including Creative Universe, Creativity Australia and With One Voice, Umbrella Foundation, Creative Innovation Global, Pot-Pourri and The Song Room.

Tania was named in the 100 Women of Influence, the 100 Australian Most Influential Entrepreneurs and named as one of the 100 most influential people in psychedelics globally in 2021. Tania’s TED Talk has sparked international interest. Tania has garnered an international reputation as a performer, speaker, entrepreneur and a passionate leader for social change. Her mission is to change the world, one voice at a time!

Peter Hunt AM

B.Com, LL.B

Founder & Chair of Mind Medicine Australia

As an investment banker Peter Hunt AM advised local and multi-national companies and governments in Australia for nearly 35 years.  He co-founded one of Australia’s leading investment banking advisory firms, Caliburn Partnership and was Executive Chairman of Greenhill Australia. Peter was a member of the Advisory Panel of ASIC and chaired the Vincent Fairfax Family Office.

Peter is an active philanthropist involved in funding, developing and scaling social sector organisations which seek to create a better and fairer world.  He is Chairman of Mind Medicine Australia which he established with his wife, Tania de Jong, in 2018. He regularly presents to Governments, regulators, clinicians, philanthropists and the general public on psychedelic-assisted therapies and the legal and ethical frameworks needed to ensure these treatments can be made accessible and affordable. He was the lead author of Mind Medicine Australia’s successful rescheduling applications for MDMA and psilocybin, which made Australia the first country in the world to reschedule these medicines.

He founded Women’s Community Shelters in 2011. Peter is a Director of The Umbrella Foundation. Peter also acts as a pro bono adviser to Creativity Australia.  He was formerly Chairman of So They Can, Grameen Australia and Grameen Australia Philippines.

Peter was made a member of the General Division of the Order of Australia in the Queen’s Birthday Honours List in 2010 for services to the philanthropic sector.

Disclaimer: Mind Medicine Australia does not encourage or facilitate illegal use of psychedelics or plant medicines. MMA focus is focused on clinical and legal use only supported by the emerging science and legislative processes. Mind Medicine Australia reserves the right to record and publish webinars on various social media platforms. You agree that you will not discuss any names, locations or specific details of illegal use of psychedelics both verbally or via any written forms of communication via Mind Medicine Australia social media platforms (for example Facebook, Instagram or Zoom private and public chat forms during a webinar). Breaches of these guidelines may result in not being able to participate in the event. We thank you for support and cooperation on these matters.

Subscribe to our newsletter

Stay in touch with Mind Medicine Australia:

×